Sign in with Google
bullish
Jacobio: Updated Valuation and Other Thoughts
490 Views04 Dec 2020 00:29
This Insight updates our NPV (reduce by ~US$100MM) of Jacobio, analyzes the use of proceeds, and has a list of 2021 events. We will give our opinion of the deal in a future Insight closer to pricing.
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Aviva’s £3.7B Acquisition: Key Index Changes
- Ohayo Japan | Wall Street Ends Volatile April Higher on Tech Boost
- FnGuide Top10 Index Rebalance Preview: Big Flow in Large Cap Stocks
- Aisin (7259) - Executing the Capital Policy Side of Its MTMP - Big ¥120bn (8.8%) Buyback
- (Mostly) Asia M&A, Apr 2025 Wrap: Toyota, Abacus Storage, Bright Smart, Fujitsu General, Topcon
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- China Healthcare: Macro Themes18 Dec 2020
- Jacobio: Management Solves for Valuation10 Dec 2020
- Jacobio Pharma IPO Initiation: Drugging the Undruggable05 Dec 2020
- Jacobio: Updated Valuation and Other Thoughts04 Dec 2020
- Jacobio Pharma: More Thinking on Valuation20 Nov 2020
- Jacobio Pharma: Focus on Novel Targets20 Oct 2020
- Jacobio (加科思药业) Pre-IPO: Right Team but Long Time to Market14 Oct 2020
x